3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Stomach Neoplasms
14
Prostatic Neoplasms
13
Colorectal Neoplasms
13
Neoplasms
12
Pancreatic Neoplasms
10
Endometrial Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Lung Neoplasms
7
Colonic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Oropharyngeal Neoplasms
5
Multiple Myeloma
5
Mouth Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Sarcoma
4
Recurrence
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Interventions
fludarabine phosphate
7
Whole-Body Irradiation
6
Melphalan
6
Peripheral Blood Stem Cell Transplantation
5
Stem Cell Transplantation
4
Mycophenolic Acid
4
Antibodies
4
thymoglobulin
3
Tacrolimus
3
Methotrexate
3
Cyclophosphamide
3
Busulfan
3
Antilymphocyte Serum
3
Alemtuzumab
3
Cyclosporine
2
treosulfan
1
merphos
1
fludarabine
1
X-Rays
1
Transplantation, Homologous
1
Thiotepa
1
Sirolimus
1
Rituximab
1
Observation
1
Muromonab-CD3
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Drug Therapy
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hemoglobinuria, Paroxysmal
×
Observation
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled